-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Health Procurement Architecture
UNDP COs are strongly recommended to procure all health products through the Health Procurement Architecture defined by UNDP GHPC. This architecture ensures procurement of health products that are compliant with the overall UNDP QA policy.
All procurement of health products that is financed through the Global Fund, where UNDP is either the PR or has signed a Financing Agreement (FA) with another PR, must be implemented via the Health Procurement Architecture defined by UNDP GHPC.
To ensure full compliance with UNDP’s QA Policy and to mitigate against of risks which are unique to health product procurement, UNDP COs that implement procurement of health products using funds outside of Global Fund grants, are strongly recommended to procure all health products through the UNDP GHPC. COs that implement procurement of health products outside of the UNDP GHPC must develop a procurement sourcing and risk management strategy in consultation and agreement with the relevant Regional Bureau, BPPS (HHG/GFPHST), and BMS (health procurement team) [1]. The strategy should determine how the best value for money and lowest risk is achieved using either CO-led procurement or the specialized services of the BPPS/BMS Global Health Procurement Center (GHPC) while taking into account the relevant project aspect. Furthermore, the strategy should agree on a GMS cost sharing arrangement, as applicable.
All LTAs for health products that have been established centrally by the GHPC are closed and are only available for use by the GHPC HPS team.
UNDP GHPC’s Health Procurement Architecture comprises several partnership and sourcing agreements with other UN Agencies, and with manufacturers and other commercial entities. This is described in subsequent sections of this HPM Manual. For each defined product category, a standard sourcing mechanism has been established.
When procurement actions are channelled through UNDP’s Health Procurement Architecture, Country Offices do not need to launch separate tender exercises for price comparison purposes or to obtain further internal approvals (Contract, Asset and Procurement (CAP) and/or Advisory Committee on Procurement (ACP) approval and QA approval). These processes have already been completed with respective organizations/units as part of the establishment of the long-term agreements (LTAs) that comprise the central procurement architecture, in accordance with internal United Nations procurement rules and regulations.
![](/images/icons/ic-light.png)
To identify the channel to use for sourcing health products, please refer to the Health Procurement Architecture. If you are unable to find the product category under the Health Procurement Architecture, please contact the GHPC Health Procurement Services Team, based in UNDP, Copenhagen.
It is important, however, for requesting units to observe the standard operating procedures (SOPs) developed by the UNDP HPS team for each of the sourcing options, and to consult with UNDP HPS focal points should any questions arise.
Furthermore, regular analysis of health procurement by Country Offices and the HPS Team serves as a basis for further development of the UNDP health procurement architecture (e.g., the establishment of new global LTAs based on the growing needs in countries). This is particularly important for products that UNDP supports countries to procure outside of the Global Fund portfolio, such as medicines for non-communicable diseases (NCDs). This will be done through a regular review of the product categories being supplied to countries.
UNDP developed a Guidance Note for UNDP Country Offices providing Health Procurement Services to governments, which is available here. The centralized procurement arrangements and services available to UNDP Country Offices promote affordable costs and value for money.
[1] OPG Decisions, 19 November 2017
Additional guidance to support this area of work are also available through resources listed below:
Loading resources
![](/images/spinner.gif)